Biomerica, Inc.
NASDAQ:BMRA
0.32 (USD) • At close December 27, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Biomerica, Inc. |
Symbool | BMRA |
Munteenheid | USD |
Prijs | 0.315 |
Beurswaarde | 5,305,533 |
Dividendpercentage | 0% |
52-weken bereik | 0.24 - 1.35 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Zackary S. Irani |
Website | https://www.biomerica.com |
An error occurred while fetching data.
Over Biomerica, Inc.
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)